Table: begin end state 1 11 cytoplasmic 12 31 transmembrane 32 36 non-cytoplasmic 37 56 transmembrane 57 67 cytoplasmic 68 86 transmembrane 87 106 non-cytoplasmic 107 136 transmembrane 137 147 cytoplasmic 148 172 transmembrane 173 183 non-cytoplasmic 184 208 transmembrane 209 227 cytoplasmic 228 254 transmembrane 255 259 non-cytoplasmic 260 275 transmembrane 276 293 cytoplasmic 294 314 transmembrane 315 333 non-cytoplasmic 334 362 transmembrane 363 371 cytoplasmic 372 400 transmembrane 401 425 non-cytoplasmic 426 447 transmembrane 448 503 cytoplasmic
Input: >AZOBR_RS20015 MAAFLIENMAPLMFAALVLFLLMGFPVAFALAANGLLFGLIGIELGLLTPALFQALPERV FGIMRNDTLLAIPFFTFMGLILERSGMAEDLLDTVGQLFGPLRGGLAYAVIFVGALLAAT TGVVAASVISMGLISLPIMLRYGYDRRLASGVIAASGTLAQIIPPSLVLIILADQLGRSV GDMYAGALVPGLVLTGLYAGYILVVSIVRPEFTPALPPEARSLRGFQLLFRVLTSLVPPL VLIFLVLGTIFIGIATPTEGGAMGAAGAMILALMKRQLSWSLMRQAMDTTAKLSSFVIFI LIGSTVFGLVFRAVNGDLWVEHLLTSLPGGELGFLIVVNIMVFLLAFFLDFFELAFIIVP LLAPVAEKLGIDLIWFGVLLGVNMQTSFMHPPFGFALFFLRSVAPREDYKDKITGKIIKK ITTGQIYWGAVPFVCIQLIMVALVIMFPEMVFSGLDRGEPIDLDNVKIEIPAFDSGEPPP PFGAPEQPAEDPNADLMRQLQGK
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server